Medical News

RSS

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.

25 Sep 2009

Jazz Semiconductor offers its Reliability Modeling Tool for high reliability applications in medical markets

Jazz Semiconductor, Inc., a Tower Group Company, today announced its pioneering Reliability Modeling Tool (RMT), offered free to its customers through its eBizz Web portal. The tool is critical for high reliability applications in aerospace, defense, automotive and medical markets.

25 Sep 2009

DOR Biopharma to raise $3.85 million from institutional investors

DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.

25 Sep 2009

Hamilton Health Sciences contravening the collective agreement: Registered nurses of ONA

Thirty-seven registered nurses, members of the Ontario Nurses' Association (ONA) will attend an arbitration hearing in Hamilton tomorrow that will decide whether Hamilton Health Sciences will be allowed to continue to arbitrarily reassign nurses to other vacant positions within the hospital.

25 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Noveko International

Noveko International Inc. ("the Company") today announces the financial results for its fourth quarter and fiscal year ended June 30, 2009.

25 Sep 2009

Levin Group to develop a practice integration program for BIOLASE dental lasers

BIOLASE Technology, Inc. today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices.

25 Sep 2009

Growing public support for the use of ignition interlocks on the cars of drunk drivers: IIHS study

While a study released last week by the Insurance Institute for Highway Safety (IIHS) indicates growing public support for the use of ignition interlocks on the cars of drunk drivers, a growing body of justice officials and policymakers say the trend is actually dealing with the people--not just the cars--when it comes to mitigating the social and financial costs of the DUI epidemic.

25 Sep 2009

Dyax to present an update of its clinical development programs

Dyax Corp., a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6th at The New York Palace Hotel in New York City, NY.

25 Sep 2009

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its clinical development of ALT-801, a novel tumor-targeted immunotherapeutic designed to improve the efficacy and safety of the FDA-approved anticancer cytokine, interleukin-2 (IL-2).

25 Sep 2009

Investigational New Drug application for Uricase-PEG 20 approved

EnzymeRx, LLC, a clinical-stage biotechnology company, announced that its Investigational New Drug (IND) application for Uricase-PEG 20, filed with the U.S. Food and Drug Administration (FDA) last month, has become effective.

25 Sep 2009

AABM Team wins two medals in a national contest

The Aquatic Animal Bio-Medicine R&D Team (AABM Team) of National Cheng Kung University (NCKU) in Taiwan, led by Distinguished Prof. Huey-Lang Yang from Institute of Biotechnology, won two medals out of more than 100 teams in the national contest, “2009 Crazy Idea – King of Practical Applications on Creative Researches and Development of Biotechnology,” organized by the Industrial Development Bureau of the Ministry of Economic Affairs, Taiwan.

25 Sep 2009

Schumer's amendment to the health bill will benefit people with disabilities: United Spinal Association

United Spinal Association praised New York Senator Charles Schumer for introducing an amendment to the Senate Finance Committee health care reform bill to enact the Community Choice Act benefiting people with disabilities.

25 Sep 2009

Susan G. Komen Race for the Cure to raise public awareness about breast cancer

A sea of pink t-shirts will stretch from Athens to Bologna to Frankfurt to Zurich to Antwerp today in an effort to raise public awareness about breast cancer. In five cities across Europe, breast cancer survivors, their families, friends, supporters and advocates will join forces in a show of strength, courage and solidarity.

25 Sep 2009

BSD Medical Corporation announces the filing of shelf registration statement with SEC

BSD Medical Corporation today announced the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission.

25 Sep 2009

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

YM BioSciences Inc. a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational and financial results for its fiscal year end, ended June 30, 2009.

25 Sep 2009

ethica Clinical Research, Matrix Pharma sign worldwide agreement

ethica Clinical Research Inc. ("ethica"), a Contract Research Organization (CRO) headquartered in Montreal, and Matrix Pharma Canada Inc. ("Matrix Pharma"), have announced the signing of an agreement, valued at CAD1.25 Million, that provides ethica with an exclusive, worldwide license to promote and use Matrix Pharma's proprietary research data analysis technology for life sciences applications, notably for the identification and optimization of biomarkers.

25 Sep 2009

Free online guide for health care organizations to improve patient care

Lilly USA and the National Committee for Quality Assurance have collaborated to release a free online guide and resource library for health care organizations that wish to undertake quality improvement initiatives to improve culturally and linguistically appropriate services and reduce disparities in care.

25 Sep 2009

Link between flicking colours and epileptic fits discovered

Researchers have discovered that epileptic brains are more ordered than non-epileptic ones and also that certain flicking colours seem more likely to cause fits.

25 Sep 2009

The Siebel Foundation to fund fellowships for Jacob School's top bioengineering graduate students

As breakthrough discoveries in bioengineering become more crucial to fundamental global issues, including health, food production and water supplies, UC San Diego's Jacobs School of Engineering's top ranked bioengineering department continues to be on the cutting edge of this field. The Siebel Foundation has recognized the Jacob School's pioneering efforts with a $2 million endowment to fund fellowships for some of its top bioengineering graduate students.

25 Sep 2009

Three-day meeting to discuss breakthroughs in prostate cancer

Nearly of 300 of the world’s leading researchers focused on the problem of prostate cancer will begin a three-day meeting today to discuss the latest scientific data and breakthroughs in prostate cancer. The meeting, held in Incline Village at Lake Tahoe in Nevada, is the 16th Scientific Retreat sponsored by the Prostate Cancer Foundation (PCF).

25 Sep 2009

Medical News

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

Jazz Semiconductor offers its Reliability Modeling Tool for high reliability applications in medical markets

DOR Biopharma to raise $3.85 million from institutional investors

Hamilton Health Sciences contravening the collective agreement: Registered nurses of ONA

Fourth-quarter and fiscal year end 2009 results announced by Noveko International

Levin Group to develop a practice integration program for BIOLASE dental lasers

Growing public support for the use of ignition interlocks on the cars of drunk drivers: IIHS study

Dyax to present an update of its clinical development programs

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

Investigational New Drug application for Uricase-PEG 20 approved

AABM Team wins two medals in a national contest

Schumer's amendment to the health bill will benefit people with disabilities: United Spinal Association

Susan G. Komen Race for the Cure to raise public awareness about breast cancer

BSD Medical Corporation announces the filing of shelf registration statement with SEC

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

ethica Clinical Research, Matrix Pharma sign worldwide agreement

Free online guide for health care organizations to improve patient care

Link between flicking colours and epileptic fits discovered

The Siebel Foundation to fund fellowships for Jacob School's top bioengineering graduate students

Three-day meeting to discuss breakthroughs in prostate cancer

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News